作者: A. Raciborska , K. Bilska , K. Drabko , E. Michalak , R. Chaber
DOI: 10.1007/S12094-015-1351-6
关键词: Internal medicine 、 Medicine 、 Diagnostic accuracy 、 In patient 、 Chemotherapy 、 Oncology 、 Pathology 、 Sarcoma 、 Prognostic factor 、 18f fdg pet
摘要: Background Response to chemotherapy is a prognostic factor in patients with Ewing sarcoma (ES); the role of FDG PET predict response these has not been thoroughly investigated. We evaluated diagnostic accuracy and potential (CHT).